Senior Vice President, Chief Marketing Officer, b1BANK
b1BANK Announces Senna Bayasgalan as Chief Marketing Officer
February 13, 2025 17:51 ET | b1BANK
BATON ROUGE, La., Feb. 13, 2025 (GLOBE NEWSWIRE) -- b1BANK, announces the appointment of Senna Bayasgalan as chief marketing officer. Bayasgalan will lead brand and marketing technology initiatives...
PDF Logo 600x400 HZ.png
PDF Solutions® Announces Record 2024 Fourth Quarter and Full Year Total Revenues
February 13, 2025 17:17 ET | PDF Solutions, Inc.
SANTA CLARA, Calif., Feb. 13, 2025 (GLOBE NEWSWIRE) -- PDF Solutions, Inc. (Nasdaq: PDFS), a leading provider of comprehensive data solutions for the semiconductor and electronics ecosystem, today...
Profound_Logo_CMYK copy.jpg
Profound Medical to Release Fourth Quarter and Full Year 2024 Financial Results on March 6 – Conference Call to Follow
February 13, 2025 17:00 ET | Profound Medical Corp.
TORONTO, Feb. 13, 2025 (GLOBE NEWSWIRE) -- Profound Medical Corp. (NASDAQ:PROF; TSX:PRN) (“Profound” or the “Company”), a commercial-stage medical device company that develops and markets...
Outset-ID-OrangeGrey.png
Outset Medical Announces Resolution of Warning Letter
February 13, 2025 16:35 ET | Outset Medical, Inc.
SAN JOSE, Calif., Feb. 13, 2025 (GLOBE NEWSWIRE) -- Outset Medical, Inc. (Nasdaq: OM) (“Outset”), a medical technology company pioneering a first-of-its-kind technology to reduce the cost and...
NeuroPace Logo.png
NeuroPace Announces Proposed Public Offering of $65 Million of Common Stock
February 13, 2025 16:34 ET | NeuroPace, Inc.
MOUNTAIN VIEW, Calif., Feb. 13, 2025 (GLOBE NEWSWIRE) -- NeuroPace, Inc. (Nasdaq: NPCE) today announced that it intends to offer and sell, in an underwritten public offering, $65 million of shares...
Tevogen Logo Notified.png
Tevogen Bio CEO Congratulates RFK Jr. on His Confirmation as Secretary of the HHS; Echoes Commitment to Innovation and Affordability for Americans
February 13, 2025 16:34 ET | Tevogen Bio Inc
WARREN, N.J., Feb. 13, 2025 (GLOBE NEWSWIRE) -- Ryan Saadi, MD, MPH, Founder and CEO of Tevogen Bio (“Tevogen Bio Holdings Inc.” or “Company”) (Nasdaq: TVGN), a clinical-stage specialty...
orrstown logo.jpg
Orrstown Financial Services, Inc. Announces Promotion of Adam Metz to Senior Executive Vice President and Chief Operating Officer
February 13, 2025 16:30 ET | Orrstown Financial Services, Inc.
HARRISBURG, Pa., Feb. 13, 2025 (GLOBE NEWSWIRE) -- Orrstown Financial Services, Inc. (NASDAQ: ORRF) (the “Company”) today announced that Adam L. Metz has been promoted to Senior Executive Vice...
allogene.png
Allogene Therapeutics Announces Publication of Durable Response Data from Phase 1 ALPHA/ALPHA2 Trials of the Allogeneic CAR T Cemacabtagene Ansegedleucel/ALLO-501 in Relapsed/Refractory Large B-Cell Lymphoma in the Journal of Clinical Oncology
February 13, 2025 16:30 ET | Allogene Therapeutics, Inc.
Efficacy Comparable to Approved Autologous CD19 CAR Ts: Achieved Overall Response (ORR) and Complete Response (CR) Rates of 58% and 42% Across the Study and 67% and 58% with Pivotal Study Regimen,...
Travere-TxTM-Inline-fullcolor.png
Travere Therapeutics to Report Fourth Quarter and Full Year 2024 Financial Results
February 13, 2025 16:30 ET | Travere Therapeutics, Inc.
SAN DIEGO, Feb. 13, 2025 (GLOBE NEWSWIRE) -- Travere Therapeutics, Inc. (NASDAQ: TVTX) today announced it will report fourth quarter and full year 2024 financial results on Thursday, February 20,...
Esperion Logo (primary).png
Esperion Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
February 13, 2025 16:30 ET | Esperion Therapeutics, Inc.
ANN ARBOR, Mich., Feb. 13, 2025 (GLOBE NEWSWIRE) -- Esperion (NASDAQ: ESPR) today announced that on February 11, 2025, the Company granted ten new employees 58,300 restricted stock units (RSUs)...